Position in GMAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,492,023
+$1,516,619 QoQ
Shares Held
90,718
+149.5% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#60
of 292 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 7%
Shared 0%
None 93%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Integrated Quantitative Investments LLC holds $8,725,728 across 13 Biotechnology names. GMAB ranks #1 (28.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
This page
|
90,718 | $2,492,023 | |
| 2 | RAPP |
Rapport Therapeutics, Inc.
|
30,386 | $1,266,184 | |
| 3 | PRAX |
Praxis Precision Medicines, Inc.
|
3,173 | $1,062,288 | |
| 4 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
146,065 | $911,445 | |
| 5 | PGEN |
Precigen, Inc.
|
90,655 | $516,733 | |
| 6 | CLYM |
Climb Bio, Inc.
|
31,406 | $409,534 | |
| 7 | ABUS |
Arbutus Biopharma Corp
|
79,937 | $383,697 | |
| 8 | INCY |
Incyte Corp
|
3,301 | $374,201 |
All Filings in GMAB
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,492,023 | 90,718 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $975,404 | 36,355 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||